From R&D Space to GMP Facilities
From R&D Space to GMP Facilities
The Next Generation of Life Sciences Facilities
Exploring the critical design, regulatory and operational considerations for delivering high-performing life sciences facilities
The UK’s life sciences sector is experiencing unprecedented growth, driven by innovation, investment, and the increasing convergence of research, development, and manufacturing. As demand for specialised facilities intensifies, developers and investors are seeking to understand how to create spaces that meet the distinct requirements of both R&D environments and GMP (Good Manufacturing Practice) facilities.
G&T partners Richard Lee-Cunningham, Trevor Springham, and Daniel Webster, along with associate director Dan Levett, explored how to balance scientific functionality, flexibility, and compliance while achieving commercial viability and futureproofing assets in a rapidly evolving market, sharing practical insights to help investors, designers, and operators navigate the complexities of developing or refurbishing spaces that support cutting-edge discovery and scalable production. Read the full article here.
